rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ATHE
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Alterity Therapeutics to Present at the Virtual Bell Potter Healthcare Conference
      Nov 12Yahoo FinanceATHE
      Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update
      Oct 30Yahoo FinanceATHE
      Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
      Oct 9Yahoo FinanceATHE
      Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
      Oct 5Yahoo FinanceATHE
      Analysts’ Top Healthcare Picks: Tandem Diabetes Care (TNDM), Alterity Therapeutics (ATHE)

      Detailed price information for Alterity Therapeutics Ltd ADR (ATHE-Q) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailATHETNDM
      Alterity Therapeutics Sets 2026 AGM Date and Director Nomination Deadline

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Sep 25The Globe and MailATHE
      Alterity Therapeutics to Spotlight MSA Program at ASX SMIDcaps Conference

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Sep 18The Globe and MailATHE
      Alterity Therapeutics Seeks Quotation for New ASX Shares

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Sep 16The Globe and MailATHE
      Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target
      Sep 16Yahoo FinanceATHE
      Alterity Therapeutics at Cantor healthcare conference: phase iii path sharpens
      Sep 11Investing.comATHE
      Alterity Therapeutics Seeks ASX Quotation for 8.4 Million New Shares

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Sep 8The Globe and MailATHE
      Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026

      MELBOURNE, Australia and SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer, will participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 on Friday, September 11, 2026 at 10:20 a.m. ET in the United States. A link to the live

      Sep 3Yahoo FinanceATHE
      Alterity Director Peter Marks Converts Options, Lifts Equity Stake

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Sep 3The Globe and MailATHE
      Alterity Therapeutics Seeks ASX Quotation for New Ordinary Shares

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Sep 2The Globe and MailATHE
      Alterity Therapeutics Files 2026 Annual Report and XBRL Data with SEC

      Tipranks Press Release.

      Sep 1The Globe and MailATHE
      Alterity Therapeutics Doubles Annual Loss as It Ramps Up Neurodegeneration R&D

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Aug 29The Globe and MailATHE
      Alterity Therapeutics Files Updated Corporate Governance Statement with ASX

      Detailed price information for Alterity Therapeutics Limited (PRNAF) from The Globe and Mail including charting and trades.

      Aug 29The Globe and MailATHE

      This is the newest page. Registered accounts read further back.